Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and Type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China.
Yang T, Liu Y, Li L, Zheng Y, Wang Y, Su J, Yang R, Luo M, Yu C.
Cardiovasc Diabetol. 2022 Jun 3;21(1):93. doi: 10.1186/s12933-022-01531-7.
PMID:35659300
Multiple triglyceride-derived metabolic indices and incident cardiovascular outcomes in patients with type 2 diabetes and coronary heart disease.
Tao S, Yu L, Li J, Huang L, Xue T, Yang D, Huang X, Meng C.
Cardiovasc Diabetol. 2024 Oct 14;23(1):359. doi: 10.1186/s12933-024-02446-1.
PMID:39402572
Proteomic signatures of type 2 diabetes predict the incidence of coronary heart disease.
Li Y, Li D, Lin J, Zhou L, Yang W, Yin X, Xu C, Cao Z, Wang Y.
Cardiovasc Diabetol. 2025 Mar 14;24(1):120. doi: 10.1186/s12933-025-02670-3.
PMID:40087642
Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations.
Zarkasi KA, Abdul Murad NA, Ahmad N, Jamal R, Abdullah N.
Int J Environ Res Public Health. 2022 Jan 6;19(2):647. doi: 10.3390/ijerph19020647.
PMID:35055468
Intensified glycemic control by HbA1c for patients with coronary heart disease and Type 2 diabetes: a review of findings and conclusions.
Chen J, Yin D, Dou K.
Cardiovasc Diabetol. 2023 Jun 22;22(1):146. doi: 10.1186/s12933-023-01875-8.
PMID:37349787
MicroRNA 155, Factor XIII and Type 2 Diabetes Mellitus and Coronary Heart Disease.
Ntanyane Phasha MA, Soma P, Rooy MV, Phulukdaree A.